Zobrazeno 1 - 10
of 83
pro vyhledávání: '"35"'
Autor:
Omar, Abdel-Rahman, Sunita, Ghosh
Publikováno v:
American Journal of Clinical Oncology. 45:338-343
The objective of this study was to evaluate the incidence and outcomes of adults with early-onset (20 to 34 y) diagnosis of well-differentiated neuroendocrine neoplasms.Surveillance, Epidemiology, and End Results (SEER)-18 database was accessed, and
Autor:
Ken Katono, Michiko Kimura, Maiko Asakuma, Michiko Yamamoto, Hisashi Mitsufuji, Masaru Kubota, Jiichiro Sasaki, Sakiko Otani, Akira Takakura, Noriyuki Masuda, Mayuko Wada, Masato Katagiri, Mikiko Ishihara, Tomoya Fukui, Satoshi Igawa, Nobuatsu Hayashi, Shinichiro Ryuge, Masanori Yokoba, Hideyuki Saito, Masashi Kasajima, Issei Toyooka, Akinobu Hamada, Yasuhiro Hiyoshi, Sachiyo Maki
Publikováno v:
American Journal of Clinical Oncology. 38:405-410
Objectives We conducted a phase I trial of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, combined with amrubicin, a topoisomerase II inhibitor. The aim was to determine the maximum tolerated dose, the dose-limiting toxicit
Autor:
Dwight E. Heron, Jean-Claude M. Rwigema, Annette E. Quinn, Michael K. Gibson, Steven A. Burton, Robert L. Ferris
Publikováno v:
American Journal of Clinical Oncology. 34:165-172
PURPOSE Locally recurrent head and neck squamous cell carcinoma can be treated with curative intent by surgical salvage or reirradiation with or without chemotherapy. We have previously demonstrated the feasibility and safety of stereotactic body rei
Autor:
Russell W. Hinerman, Ilona M. Schmalfuss, William M. Mendenhall, Christopher G. Morris, Anna Rabbani, Robert J. Amdur, Keith R. Peters, K. Thomas Robbins
Publikováno v:
American Journal of Clinical Oncology. 30:283-286
Review of the University of Florida experience in treating advanced squamous cell carcinomas of the head and neck with concurrent intraarterial cisplatin and radiotherapy (RADPLAT).Thirty-five patients with Stage III or IV head and neck squamous cell
Autor:
Merle M. Salter, Richard H. Wheeler, Wendy Conner, Glenn E. Peters, Sharon A. Spencer, Judy Smith, Samuel W. Beenken, Ruby F. Meredith
Publikováno v:
American Journal of Clinical Oncology. 22:1-5
Thirty-five patients with inoperable recurrent head and neck cancer previously treated with definitive irradiation were treated with reirradiation and concomitant chemotherapy. Patient records were retrospectively reviewed to assess toxicity, respons
Autor:
Yukikazu Ichimaru, Naruo Yoshimura, Shigenori Kyoh, Shinzoh Kudoh, Kazuhisa Asai, Yoshihiro Tochino, Shigeki Mitsuoka, Kazuto Hirata, Tatsuo Kimura
Publikováno v:
American journal of clinical oncology. 36(2)
OBJECTIVES Cisplatin is a key drug used in the treatment of non-small cell lung cancer (NSCLC), and amrubicin is one of the new active agents for NSCLC. The objective of this study was to determine the recommended dose (RD) of amrubicin in combinatio
Autor:
Rahamim Ben-Yosef, Orit Kaidar-Person, Nissim Haim, Katerina Shulman, Samar Musallam, Ron Epelbaum
Publikováno v:
American Journal of Clinical Oncology. 43:861-864
OBJECTIVES Oncological treatments of older patients have many unresolved questions mainly because of the fact that these patients were not eligible to be included in most clinical trials. The aim of this study was to evaluate the treatment approach t
Autor:
Nicholas B Figura, S. Sarangkasiri, Daniel E. Oliver, Andrew Keller, Austin J. Sim, Hsiang-Hsuan Michael Yu, Timothy J. Robinson, Kamran Ahmed, Peter A.S. Johnstone, Arash O. Naghavi
Publikováno v:
American Journal of Clinical Oncology. 43:356-361
OBJECTIVES The brain is a rare site for sarcoma metastases. Sarcoma's radioresistance also makes standard whole-brain radiotherapy less appealing. We hypothesize that stereotactic radiation techniques (stereotactic radiosurgery [SRS]/stereotactic fra
Autor:
Burkhard Weppelmann, Richard H. Wheeler, Ruby F. Meredith, Suzanne Stephens, Glenn E. Peters, Sharon A. Spencer, Robert Y. Kim, M M Salter
Publikováno v:
American Journal of Clinical Oncology. 15:461-463
Cisplatin (CDDP) and 5-fluorouracil (5-FU) have been used alone, in combination, and in various doses and sequences with radiation therapy in attempts to improve local control and survival of patients with advanced head and neck cancer. This study wa
Publikováno v:
American journal of clinical oncology. 23(3)
Sixty patients with squamous cell carcinoma (SCC) of the lung, including 25 cases with recurrence and 35 cases without recurrence 1 year after operation, were enrolled in this study. The serial serum levels of cytokeratin fragment 19 (CYFRA 21-1) and